Ticker Details
BridgeBio Pharma, Inc.
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$17.66B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.99 | 3.23%
Avg Daily Range (30 D):	$1.23 | 1.72%
Avg Daily Range (90 D):	$1.43 | 2.03%

Institutional Daily Volume
Avg Daily Volume:	1.54M
Avg Daily Volume (30 D):	3.18M
Avg Daily Volume (90 D):	2.42M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	85
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	9,071
Avg Institutional Trade:	$3.66M
Avg Institutional Trade (30 D):	$8.65M
Avg Institutional Trade (90 D):	$6.19M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$8.91M
Avg Closing Trade (30 D):	$51.83M
Avg Closing Trade (90 D):	$29.64M
Avg Closing Volume:	258.98K

News

Jul 7, 2026 @ 10:42 AM Transthyretin Amyloidosis Treatment Market Size to... Source: Sns Insider

Jul 2, 2026 @ 10:33 AM Wall Street Thinks This Biotech Stock Can Soar 45%... Source: James Halley

Jul 1, 2026 @ 11:30 AM BridgeBio Raises $1 Billion in Preferred Equity to... Source: Na

May 12, 2026 @ 12:30 PM Wall Street's Cardiac Bet: Where Diagnostics Meet ... Source: Usa News Group

Mar 30, 2026 @ 7:30 PM Acoramidis Significantly Reduces the Risk of All-C... Source: Bridgebio Pharma, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.73	$-.84
Diluted EPS	$-3.73	$-.84
Revenue	$579.96M	$194.52M
Gross Profit	$551.7M	$184.58M
Net Income / Loss	$-729.89M	$-166.56M
Operating Income / Loss	$-525M	$-105.96M
Cost of Revenue	$28.26M	$9.94M
Net Cash Flow	$339.28M	$309.88M
PE Ratio